BTIG analyst Marie Thibault Quoted by Investor’s Business Daily – “IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls”
BTIG analyst Marie Thibault said in a recent report: “Commercial insurance companies are signing off on G7 coverage quicker than Dexcom anticipated. Commentary sounded upbeat on G7 adoption. Management confirmed their expectation that these new patients would contribute 1% of total revenue this year. We think this remains a relatively conservative target given 75% of Dexcom reps are targeting (primary care physicians) and we think physician/patient awareness will increase into the catalyst.” She kept her buy rating and 126 price target on Dexcom stock.